Cargando…
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: A Short Comment [Letter]
Autor principal: | Rastmanesh, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487799/ https://www.ncbi.nlm.nih.gov/pubmed/34616184 http://dx.doi.org/10.2147/CLEP.S339834 |
Ejemplares similares
-
Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
por: Andreassen, Bettina K, et al.
Publicado: (2021) -
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort
por: Hektoen, Helga H, et al.
Publicado: (2021) -
Prediagnostic serum 25-hydroxyvitamin D and melanoma risk
por: Stenehjem, Jo S., et al.
Publicado: (2020) -
Prediagnostic Serum Organochlorine Concentrations and Metastatic Prostate Cancer: A Nested Case–Control Study in the Norwegian Janus Serum Bank Cohort
por: Koutros, Stella, et al.
Publicado: (2015) -
Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate
por: Grant, William B.
Publicado: (2012)